StonvexLoading…
StonvexStonvexStonvexCore line items from MTSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Annual 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|---|
Revenue | $342.10M | $560.57M | $271.61M | $967.26M | $706.09M |
Operating Income | Not available | $94.13M | $43.30M | $129.65M | $90.06M |
Net Income | Not available | $95.10M | $48.77M | $-54.21M | $-99.33M |
EPS (Diluted) | $1.37 | $1.23 | $0.64 | $-0.73 | $-1.35 |
Total Assets | Not available | $2.01B | $2.11B | $2.10B | $2.00B |
Total Liabilities | Not available | $596.82M | $752.41M | $776.26M | $739.92M |
Cash & Equivalents | Not available | $98.52M | $119.65M | $112.14M | $125.47M |
Free Cash Flow OCF − CapEx | Not available | $95.46M | $29.99M | $192.82M | $143.40M |
Shares Outstanding | Not available | 77.14M | 76.72M | 74.48M | 73.83M |